(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP), Wednesday announced the launch of Nitazoxanide Tablets, 500 mg that are the generic version of the reference listed drug Alinia. Nikhil Lalwani ...

ANI Pharmaceuticals (ANIP) announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the reference listed drug, or RLD, Alinia. U.S. annual ...

(ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets are the generic version of the reference listed drug (RLD) Alinia ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI's Nitazoxanide Tablets ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...

PRINCETON, N.J. – ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), a diversified biopharmaceutical company with a market capitalization of $1.3 billion and impressive revenue growth of 26.2% over the last ...

According to IQVIA data with a December 2024 moving annual total (MAT), the U.S. annual sales for Nitazoxanide Tablets are estimated at approximately $36.1 million. The release of this generic ...